TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹4,373 Cr | ₹3,704 Cr | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹4,373 Cr |
| Mar2025 | ₹3,704 Cr |
| Mar2024 | ₹3,364 Cr |
| Mar2023 | ₹2,824 Cr |
| Mar2022 | ₹2,431 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,373 Cr | 18.05 | |
| Mar2025 | ₹3,704 Cr | 10.13 | |
| Mar2024 | ₹3,364 Cr | 19.11 | |
| Mar2023 | ₹2,824 Cr | 16.15 | |
| Mar2022 | ₹2,431 Cr | - | |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹151,364.6 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
| MANKIND PHARMA | ₹98,745.3 Cr | 2.6% | -0.7% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.3% |
1.2% |
41.1% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses